Search

Issue
Title
Authors
Vol 24, No 2 (2022)
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review
Zukov R.A., Chernyaev D.V., Zulkaidarova A.R.
PDF
(Rus)
Vol 23, No 3 (2021)
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
Sarzhevskiy V.O., Melnichenko V.I., Panshina I.V., Mochkin N.E., Bogatyrov V.S., Borshevetskaya M.M., Smirnova E.G., Bannikova A.E., Samoylova A.A., Mamedova A.A., Rukavitsin A.A., Vasilev S.S., Bronov O.I.
PDF
(Rus)
Vol 23, No 2 (2021)
Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report
Protasova A.E., Strakh L.V., Lando E.I., Sidorkina E.V.
PDF
(Rus)
Vol 23, No 2 (2021)
The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report
Ognerubov N.A., Antipova T.S.
PDF
(Rus)
Vol 26, No 3 (2024)
Role of immunohistochemical prognostic factors in various types of immunotherapy for metastatic melanoma: A retro-prospective study
Oganesyan L.V., Zavalishina L.E., Ognerubov N.A., Kostalanova I.V., Kaganov O.I., Poddubnaya I.V.
PDF
(Rus)
Vol 23, No 1 (2021)
Stomach cancer. Clinical significance of the expression of key components of PD-1/PD-L1 immune checkpoint
Kovaleva O.V., Podlesnaya P.A., Gratchev A.N., Chang V.L., Ognerubov N.A., Kushlinskii N.E.
PDF
(Rus)
Vol 26, No 2 (2024)
Immunohistochemical factors of prognosis of immunotherapy for metastatic melanoma: А prospective and retrospective study
Oganesyan L.V., Zavalishina L.E., Ognerubov N.A., Kostalanova I.V., Orlov A.E., Poddubnaya I.V.
PDF
(Rus)
Vol 19, No 3 (2017)
BCD-100 - first russian PD-1 inhibitor
Tyulyandin S.A., Fedyanin M.Y., Semiglazova T.Y., Moiseenko V.M., Odintsova S.V., Alekseev B.Y., Ivanov R.A., Shustova M.S.
PDF
(Rus)
Vol 25, No 3 (2023)
News in immunotherapy for metastatic melanoma: prolgolimab in clinical practice (authors' experience)
Oganesyan L.V., Karnaukhov N.S., Feoktistova P.S.
PDF
(Rus)
Vol 26, No 3 (2024)
Retrospective analysis of the safety and efficacy of Pembroria® during non-medical switching from the original drug Keytruda® in patients with advanced malignancies of various localizations in real clinical practice
Zhukova L.G., Filonenko D.A., Polshina N.I., Smolin S.A., Pasechnyuk O.S.
PDF
(Rus)
Vol 26, No 2 (2024)
Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study
Choynzonov E.L., Fedenko A.A., Falaleeva N.A., Andreeva T.V., Afanas'ev S.G., Bakaev Z.A., Valiev D.I., Volkov A.A., Kolomiets L.A., Krashikhina T.V., Miller S.V., Mikhaliuk V.V., Ogloblin A.N., Orlova S.A., Pataliak S.V., Pokataev I.A., Popova N.O., Rebrina O.V., Safin R.N., Stradaeva I.I., Trefilova I.V., Usol'tseva I.S., Usynin E.A., Sharov S.V., Iukal'chuk D.I., Iasieva A.R.
PDF
(Rus)
1 - 11 of 11 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"